Institute of Medicine, Committee on Care at the End of Life. Not Available In: Field MJ, Cassel CK, eds. Approaching Death: Improving
Care at the End of Life. Washington, DC: National Academy Press; 1997.
SUPPORT Study Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients:
the Study to Understand Prognoses and Preferences for Outcomes and Risks of
Treatments (SUPPORT). JAMA.1995;274:1591-1598.
American Academy of Pain Medicine and American Pain Society. The Use of Opioids for the Treatment of Chronic Pain:
A Consensus Statement. Glenview, Ill: American Academy of Pain Medicine and American Pain
Federation of State Medical Boards of the United States Inc. Model Guidelines for the Use of Controlled Substances
for the Treatment of Pain. Euless, Tex: Federation of State Medical Boards of the United States
Acute Pain Management Guideline Panel. Acute pain management: operative or medical procedures and trauma. In: Clinical Practice Guideline. Rockville,
Md: Agency for Health Care Policy and Research, Public Health Service, US
Dept of Health and Human Services; 1992. AHCPR publication 92-0032.
Jacox A, Carr DB, Payne R.
et al. Management of cancer pain. In: Clinical Practice Guideline Number 9.
Rockville, Md: Agency for Health Care Policy and Research, US Dept of Health
and Human Services, Public Health Service; 1994. AHCPR publication 94-0592.
World Health Organization. Cancer Pain Relief. Geneva, Switzerland: World Health Organization; 1986.
Doyle D, Hanks GWC, MacDonald N. Oxford Textbook of Palliative Medicine. New York, NY: Oxford University Press; 1993.
United Nations. Single Convention on Narcotic Drugs, 1961. New York, NY: United Nations; 1977.
Not Available. Controlled Substances Act of 1970. Pub L No. 91-513, 84 Stat 1242.
Joranson DE. Guiding principles of international and federal laws pertaining to
medical use and diversion of controlled substances. In: Cooper JR, Czechowicz DJ, Molinari SP, Petersen RC, eds. Impact of Prescription Drug Diversion Control Systems on Medical
Practice and Patient Care: Monograph 131. Rockville, Md: National Institute
on Drug Abuse Research; 1993:18-33.
Ward SE, Berry PE, Misiewicz H. Concerns about analgesics among patients and family caregivers in a
hospice setting. Res Nurs Health.1996;19:205-211.
Paice JA, Toy C, Shott S. Barriers to cancer pain relief: fear of tolerance and addiction. J Pain Symptom Manage.1998;16:1-9.
Weissman DE. Doctors, opioids, and the law: the effect of controlled substances
regulations on cancer pain management. Semin Oncol.1993;20(2 suppl 1):53-58.
Hill Jr CS. The barriers to adequate pain management with opioid analgesics. Semin Oncol.1993;20(2 suppl 1):1-5.
Lebovits AH, Florence I, Bathina R, Hunko V, Fox MT, Bramble CY. Pain knowledge and attitudes of healthcare providers: practice characteristic
differences. Clin J Pain.1997;13:237-243.
McCaffery M. Opioids, addiction, and the terminally ill. Am J Nurs.1995;95:61-62.
Adams EH. Prevalence of prescription drug abuse: data from the National Institute
on Drug Abuse. N Y State J Med.1991;91(suppl):32S-36S.
World Health Organization. Cancer Pain Relief: With a Guide to Opioid Availability. Geneva, Switzerland: World Health Organization; 1996.
Substance Abuse and Mental Health Administration. Annual emergency department data. In: Data From the Drug Abuse Warning Network, 1994,
Number 14-A. Rockville, Md: Public Health Service, US Dept of Health
and Human Services, Office of Applied Studies; 1996. SMA publication 96-3104.
Alcohol, Drug Abuse, and Mental Health Administration. Annual emergency room data. In: Data From the Drug Abuse Warning Network, 1990,
Number 10-A. Rockville, Md: Public Health Service, US Dept of Health
and Human Services, National Institute on Drug Abuse; 1991. ADM publication
Not Available. Infant Formula Act of 1980. Pub L No. 96-359, 94 Stat 1190.
Drug Enforcement Administration. ARCOS/DADS State and Local Training Manual. Washington, DC: US Dept of Justice; 1984.
Office of Inspector General, US Department of Justice. Audit Report: The Drug Enforcement Administration
Diversion Control Program. Washington, DC: Office of Inspector General, US Dept of Justice;
Drug Enforcement Administration. ARCOS Data for Selected Opioid Analgesics, 1980-1996. Arlington, Va: US Dept of Justice; 1997.
Joranson DE, Gilson AM. Regulatory barriers to pain management. Semin Oncol Nurs.1998;14:158-163.
Kaiko RF, Foley KM, Grabinski PY.
et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol.1983;13:180-185.
Substance Abuse and Mental Health Services Administration. Population estimates. In: National Household Survey on Drug Abuse, 1997,
Number H-7. Rockville, Md: Public Health Service, US Dept of Health
and Human Services, Office of Applied Studies; 1998. SMA publication 98-3250.
Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M. 1997 Annual Report of the American Association of Poison Control Centers
Toxic Exposure Surveillance System. Am J Emerg Med.1998;16:443-497.